@article{967be59b20de45a8abdf8764714bc4e6,
title = "Specific Features Identify Patients with Relapsed/Refractory Mantle Cell Lymphoma Benefitting From Autologous Hematopoietic Cell Transplantation.",
author = "Cassaday, \{Ryan D.\} and Guthrie, \{Katherine A.\} and Budde, \{Lihua E.\} and Leslie Thompson and Till, \{Brian G.\} and Press, \{Oliver W.\} and Thomas Chauncey and Pagel, \{John M.\} and Petersdorf, \{Stephen H.\} and Bensinger, \{William I.\} and Leona Holmberg and Shustov, \{Andrei R.\} and Green, \{Damian J.\} and Libby, \{Edward N.\} and Maloney, \{David G.\} and Gopal, \{Ajay K.\}",
note = "Abstract 3636 PURPOSE: Radioimmunotherapy (RIT) studies for the treatment of acute myeloid leukemia (AML) have mostly employed antibodies (Ab) labeled with 131I or 90Y, but both radionuclides have limitations. The high-energy gamma component of 131I requires that patients be treated in isolation to minimize radiation exposure risk to staff and family, warranting consideration of alternative radionuclides.",
year = "2012",
month = nov,
day = "16",
language = "American English",
volume = "120",
journal = "Blood",
}